製品詳細
Source
Monoclonal Anti-Adenoviruses AAV9 Neutralizing Antibody, Mouse IgG1 (28B9C5) is a mouse monoclonal antibody derived from hybridoma cells fused with SP2/0 myeloma cells and murine B lymphocytes.
Antibody Type
Hybridoma Monoclonal
Clone
28B9C5
Isotype
Mouse IgG1, Kappa
Host Species
Mouse
Immunogen
AAV9
Application
ApplicationRecommended UsageELISA0.2-2 μg/mLCross Verification
This product can specially react with AAV9.
No reactivity to AAV1/ AAV2/ AAV3/ AAV5/ AAV6/ AAV8.Purification
Protein A purified / Protein G purified.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Liquid
Formulation
Supplied a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 12 months under sterile conditions.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
お客様はこちらも閲覧
データ表示
Bioactivity-ELISA

Immobilized AAV9 at 1E+10capsids/ml (100 μl/well) can bind Monoclonal Anti-Adenoviruses AAV9 Neutralizing Antibody, Mouse IgG1 (28B9C5) (Cat. No. AA9-Y2142) with a linear range of 0.50-30ng/mL (QC tested).
Protocol
ユーザーレビュー コメントを投稿

バックグランド
AAV9 has been utilized in clinical trials for various diseases, such as spinal muscular atrophy (SMA), Duchenne muscular dystrophy (DMD), and familial hypercholesterolemia.
最新の進展
メールアドレス
order.jp@acrobiosystems.comお問い合わせ
グローバル:+1 800-810-0816(Toll Free)



















